ijms-logo

Journal Browser

Journal Browser

Molecular Insights into Nutritional Neuroscience: Diet, Microbiota, and Brain Function

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Bioactives and Nutraceuticals".

Deadline for manuscript submissions: closed (31 March 2026) | Viewed by 4280

Special Issue Editor


E-Mail Website
Guest Editor

Special Issue Information

Dear Colleagues,

The intricate relationship between diet, gut microbiota, and brain function represents one of the most dynamic and promising areas within molecular neuroscience. Recent advancements in the fields of genomics, metabolomics, and neurobiology have elucidated that nutritional factors and the gut microbial ecosystem exert their effects on the brain through varied molecular mechanisms, including the regulation of gene expression, epigenetic modifications, signal transduction pathways, and the synthesis of neuroactive compounds and metabolites that cross the blood–brain barrier. Molecular crosstalk along the gut–brain axis is now recognized as a key determinant of neurodevelopment, synaptic plasticity, neuroinflammation, and overall brain health.

Elucidating these intricate molecular pathways is imperative for comprehending the role of dietary components and microbiota-derived metabolites in brain function and dysfunction. This knowledge is crucial for identifying novel biomarkers and therapeutic targets in neuropsychiatric and neurodegenerative diseases. Integrating advanced molecular techniques, ranging from transcriptomics and proteomics to metabolomics and systems biology, facilitates the precise dissection of these interactions and promotes the translation of fundamental molecular findings into clinical applications.

This Special Issue will provide an opportunity for research focused on the molecular mechanisms via which diet and the gut microbiota influence brain function in both health and disease. We particularly welcome studies that elucidate signaling pathways, molecular mediators, and omics-based signatures underpinning diet–microbiota–brain interactions. Original research articles presenting novel molecular data and comprehensive reviews summarizing current advances are encouraged.

Research areas may include (but are not limited to) the following:

  • Molecular signaling pathways mediating gut–brain communication;
  • Impact of nutrients and microbial metabolites on gene expression and epigenetic regulation in the brain;
  • Omics-based approaches (genomics, transcriptomics, proteomics, metabolomics) for deciphering the diet–microbiota–brain axis;
  • Molecular mechanisms linking diet and microbiota to neuroinflammation, oxidative stress, and neuronal plasticity;
  • Identification of molecular biomarkers associated with nutritional and microbial modulation of brain function;
  • Translational studies focused on molecular targets for intervention in neurodevelopmental, neuropsychiatric, and neurodegenerative diseases.

We look forward to receiving your contributions.

Prof. Dr. Ana Isabel Beltrán-Velasco
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nutritional neuroscience
  • gut–brain axis
  • diet
  • microbiota
  • molecular mechanisms
  • neuroinflammation
  • cognitive function
  • neurodegeneration
  • omics
  • biomarkers

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 3068 KB  
Article
Melatonin Biosynthesis, Receptors, and the Microbiota–Tryptophan–Melatonin Axis: A Shared Dysbiosis Signature Across Cardiac Arrhythmias, Epilepsy, Malignant Proliferation, and Cognitive Trajectories
by Alexandre Tavartkiladze, Russel J. Reiter, Ruite Lou, Dinara Kasradze, Nana Okrostsvaridze, Pati Revazishvili, Maia Maisuradze, George Dundua, Irine Andronikashvili, Pirdara Nozadze, David Jinchveladze, Levan Tavartkiladze, Rusudan Khutsishvili and Tatia Potskhoraia
Int. J. Mol. Sci. 2026, 27(3), 1361; https://doi.org/10.3390/ijms27031361 - 29 Jan 2026
Viewed by 3969
Abstract
Melatonin, an indolic neuromodulator with putative oncostatic and proposed anti-inflammatory properties, primarily demonstrated in preclinical models, is produced at extrapineal sites—most notably in the gut. Its canonical actions are mediated by high-affinity GPCRs (MT1/MT2) and by NQO2, a cytosolic enzyme with a melatonin-binding [...] Read more.
Melatonin, an indolic neuromodulator with putative oncostatic and proposed anti-inflammatory properties, primarily demonstrated in preclinical models, is produced at extrapineal sites—most notably in the gut. Its canonical actions are mediated by high-affinity GPCRs (MT1/MT2) and by NQO2, a cytosolic enzyme with a melatonin-binding site (historically termed “MT3”). A growing body of work highlights a bidirectional interaction between the gut microbiota and host melatonin. We integrated two lines of work: (i) three clinical cohorts—cardiac arrhythmias (n = 111; 46–75 y), epilepsy (n = 77; 20–59 y), and stage III–IV solid cancers (25–79 y)—profiled with stool 16S rRNA sequencing, SCFA measurements, and circulating melatonin/urinary 6-sulfatoxymelatonin and (ii) an age-spanning cognitive cohort with melatonin phenotyping, microbiome analyses, and exploratory immune/metabolite readouts, including a novel observation of melatonin binding on bacterial membranes. Across all three disease cohorts, we observed moderate-to-severe dysbiosis, with reduced alpha-diversity and shifted beta-structure. The core dysbiosis implicated tryptophan-active taxa (Bacteroides/Clostridiales proteolysis and indolic conversions) and depletion of SCFA-forward commensals (e.g., Faecalibacterium, Blautia, Akkermansia, and several Lactobacillus/Bifidobacterium spp.). Synthesised literature indicates that typical human gut commensals rarely secrete measurable melatonin in vitro; rather, their metabolites (SCFAs, lactate, and tryptophan derivatives) regulate host enterochromaffin serotonin/melatonin production. In arrhythmia models, dysbiosis, bile-acid remodelling, and autonomic/inflammatory tone align with melatonin-sensitive antiarrhythmic effects. Epilepsy exhibits circadian seizure patterns and tryptophan–metabolite signatures, with modest and heterogeneous responses to add-on melatonin. Cancer cohorts show broader dysbiosis consistent with melatonin’s oncostatic actions. In the cognitive cohort, the absence of dysbiosis tracked with preserved learning across ages, and exploratory immunohistochemistry suggested melatonin-binding sites on bacterial membranes in ~15–17% of samples. A unifying microbiota–tryptophan–melatonin axis plausibly integrates circadian, electrophysiologic, and immune–oncologic phenotypes. Practical levers include fiber-rich diets (to drive SCFAs), light hygiene, and time-aware therapy, with indication-specific use of melatonin. Our conclusions regarding microbiota–melatonin crosstalk rely primarily on local paracrine effects within the gut mucosa (where melatonin concentrations are 10–400× plasma levels), whereas systemic chronotherapy conclusions depend on circulating melatonin amplitude and phase. This original research article presents primary data from four prospectively enrolled clinical cohorts (total n = 577). Full article
Show Figures

Graphical abstract

Back to TopTop